Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Unither Pharmaceuticals, France
With
International Pharmaceutical Research Center
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male and non-pregnant female human subjects, age 18-50 years
Body mass index between 18.5-30 Kg/m²
Subject with normal findings
Willingness to follow the protocol requirements
You may not be if
History of hypersensitivity to tramadol hydrochloride
Significant history of asthma, thyrotoxicosis, tumours, peptic or gastric ulcer, gastrointestinal malabsorption or haemorrhage in the gastro-intestinal tract, sinusitis, pharyngitis, renal disorder (impaired renal function), hepatic disorder (impaired hepatic function), cardiovascular disorder (ex. severe heart failure), neurological disease such as epilepsy, haematological disorders or diabetes, psychiatric, dermatologic or immunological disorders
Presence of any clinically significant results from laboratory tests,
lactating female or woman of childbearing potential unwilling to use an effective contraception
Clareo Health | Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)
